Galderma Group AG
Treatment of Moderate to Severe Glabellar Lines
- Conditions
- Glabellar Frown Lines
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 300
- Registration Number
- NCT04249583
- Locations
- 🇺🇸
\Ablon Skin Institute and Research Center, Manhattan Beach, California, United States
🇺🇸Moradi MD, Vista, California, United States
🇺🇸Etre Cosmetic Dermatology and Laser Center, New Orleans, Louisiana, United States
Treatment of Moderate to Severe Lateral Canthal Lines
- Conditions
- Lateral Canthal Lines
- First Posted Date
- 2020-01-31
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 303
- Registration Number
- NCT04249687
- Locations
- 🇺🇸
Ablon Skin Institute and Research Center, Manhattan Beach, California, United States
🇺🇸Dermatology Cosmetic Laser Medical Associates, San Diego, California, United States
🇺🇸Art of Skin, MD, Solana Beach, California, United States
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination
- Conditions
- Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
- First Posted Date
- 2020-01-29
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 413
- Registration Number
- NCT04247074
- Locations
- 🇺🇸
Clinical Testing of Beverly Hills, Encino, California, United States
🇺🇸Ava MD, Santa Monica, California, United States
🇺🇸Skin Care & Laser Physicians of Beverly Hills, West Hollywood, California, United States
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
- Conditions
- Glabellar LinesLateral Canthal Lines
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 902
- Registration Number
- NCT04225260
- Locations
- 🇺🇸
Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸Investigate MD, LLC., Scottsdale, Arizona, United States
🇺🇸Center for Dermatology Clinical Research, Inc., Fremont, California, United States
Extension Study for 43USSA1705
- Conditions
- Nasolabial Folds
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 38
- Registration Number
- NCT04225273
- Locations
- 🇺🇸
Galderma Study Site, Spring, Texas, United States
A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)
- First Posted Date
- 2019-12-19
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 500
- Registration Number
- NCT04204616
- Locations
- 🇬🇧
Galderma Investigational Site, Newcastle Upon Tyne, United Kingdom
🇺🇸Galderma Investigational Galderma Investigational Site, Springville, Utah, United States
🇺🇸Galderma I Galderma Investigational Site, Lake Bluff, Illinois, United States
Restylane-L for Correction of Infraorbital Hollows
- Conditions
- Infraorbital Hollows
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2023-04-25
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 333
- Registration Number
- NCT04154930
- Locations
- 🇺🇸
Galderma Research Site, Spring, Texas, United States
Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
- Conditions
- Midface Volume Deficit
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 205
- Registration Number
- NCT04132518
- Locations
- 🇨🇳
Galderma research site 3, Beijing, China
🇨🇳Galderma research site 4, Beijing, China
🇨🇳Galderma research site 5, Chengdu, China
Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles
- Conditions
- Cheek Wrinkles
- First Posted Date
- 2019-10-11
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 149
- Registration Number
- NCT04124692
- Locations
- 🇺🇸
Galderma Research Site, Spring, Texas, United States
Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face
- Conditions
- Actinic Keratoses
- Interventions
- Drug: MAL 16.8% creamDrug: MAL Vehicle Cream
- First Posted Date
- 2019-09-11
- Last Posted Date
- 2022-04-01
- Lead Sponsor
- Galderma R&D
- Target Recruit Count
- 557
- Registration Number
- NCT04085367
- Locations
- 🇺🇸
Galderma Investigational Site (Site 8768), Tucson, Arizona, United States
🇺🇸Galderma Investigational Site (Site 8447), Fort Smith, Arkansas, United States
🇺🇸Galderma Investigational Site (Site 8577), Encinitas, California, United States